Korea Healthcare: IQVIA June US drug sales: steeper growth at quarter-end

Research evidence excerpt

Korea Healthcare: IQVIA June US drug sales: steeper growth at quarter-end

Jihyun Cho AC Asia Pacific Equity Research

(82-2) 758-5480 30 July 2026 J P M O R G A N

jihyun.cho@jpmorgan.com

Canada: J.P. Morgan Securities Canada Inc. is a registered investment dealer, regulated by the Canadian Investment Regulatory Organization

and the Ontario Securities Commission and is the participating member on Canadian exchanges. This material is distributed in Canada by or on

behalf of J.P.Morgan Securities Canada Inc.

Chile: Inversiones J.P. Morgan Limitada is an unregulated entity incorporated in Chile.

China: J.P. Morgan Securities (China) Company Limited has been approved by CSRC to conduct the securities investment consultancy

business.

Colombia: Banco J.P. Morgan Colombia S.A. is supervised by the Superintendencia Financiera de Colombia (SFC). Any reference in this

material to products or services offered abroad by entities other than the Bank in Colombia is included exclusively for descriptive purposes.

Such references do not constitute, and should not be construed as, promotional activity or the provision of financial products or services within

Colombian territory, as defined under applicable Colombian regulation.

Dubai International Financial Centre (DIFC): JPMorgan Chase Bank, N.A., Dubai Branch is regulated by the Dubai Financial Services

Authority (DFSA) and its registered address is Dubai International Financial Centre - The Gate, West Wing, Level 3 and 9 PO Box 506551,

Dubai, UAE. This material has been distributed by JP Morgan Chase Bank, N.A., Dubai Branch to persons regarded as professional clients or

market counterparties as defined under the DFSA rules.

European Economic Area (EEA): Unless specified to the contrary, research is distributed in the EEA by J.P.